Loading clinical trials...
Loading clinical trials...
Estimate the response to modified hypofractionated radiotherapy concurrent with Gemcitabine in urinary bladder cancer patients . Estimate local control, relapse free survival, overall survival and bl...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Assiut University
NCT05644041 · Urinary Bladder Cancer
NCT04861584 · Urinary Bladder Cancer
NCT03844256 · Urinary Bladder Cancer, Invasive Bladder Cancer
NCT05072600 · Bladder Cancer, Bladder Neoplasms, and more
NCT06307704 · Prostate Cancer, Urinary Bladder Cancer, and more
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions